The Race to Ritonavir: FDA Approves Second Protease Inhibitor in Record Time – As Abbott Chief Warns Many to “Wait for the data”
FDA Approves Second Protease Inhibitor in Record Time - As Abbott Chief Warns Many to "Wait for the data" And Indinavir Makes Three Treatment activists met recently with representatives from Abbott Labs at their Abbott Park, IL headquarters in advance…